Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radium-1 TCR Therapy in Metastatic Colorectal Cancer
NCT03431311Phase 2Terminated
- Sponsor
- Oslo University Hospital
- Start
- Mar 2018
- Primary completion
- Jun 2019
- Modality
- TCR-Engineered T Cells, RNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of radium-1 tcr in metastatic colorectal cancer (mCRC), sponsored by Oslo University Hospital. Started Mar 2018; status: terminated.
02
Drugs
radium-1 tcr
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT03431311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03431311.